Compare Stocks: MDV, NXRT, BRSP, and BBOT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBOT BridgeBio Oncology Therapeutics	$8.25 +2.0%	$8.16	$7.00 ▼ $14.87	$648.07M	0.35	355,701 shs	210,116 shs
BRSP BrightSpire Capital	$5.14 +2.5%	$5.45	$4.85 ▼ $6.16	$633.89M	1.29	1.58 million shs	2.01 million shs
MDV Modiv Industrial	$17.09 -1.3%	$17.93	$13.80 ▼ $18.96	$178.81M	-0.07	51,489 shs	37,234 shs
NXRT NexPoint Residential Trust	$25.97 -0.5%	$27.70	$23.79 ▼ $34.87	$665.58M	1.18	201,426 shs	429,704 shs

10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBOT BridgeBio Oncology Therapeutics	0.00%	-8.28%	-0.25%	-3.58%	+808,999,900.00%
BRSP BrightSpire Capital	0.00%	-4.06%	-7.56%	-14.36%	-3.00%
MDV Modiv Industrial	0.00%	-1.99%	-3.47%	+7.46%	+20.65%
NXRT NexPoint Residential Trust	0.00%	+0.32%	-9.03%	-9.43%	-15.07%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBOT BridgeBio Oncology Therapeutics	$8.25 +2.0%	$8.16	$7.00 ▼ $14.87	$648.07M	0.35	355,701 shs	210,116 shs
BRSP BrightSpire Capital	$5.14 +2.5%	$5.45	$4.85 ▼ $6.16	$633.89M	1.29	1.58 million shs	2.01 million shs
MDV Modiv Industrial	$17.09 -1.3%	$17.93	$13.80 ▼ $18.96	$178.81M	-0.07	51,489 shs	37,234 shs
NXRT NexPoint Residential Trust	$25.97 -0.5%	$27.70	$23.79 ▼ $34.87	$665.58M	1.18	201,426 shs	429,704 shs

10 Best Stocks to Own - Summer 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBOT BridgeBio Oncology Therapeutics	0.00%	-8.28%	-0.25%	-3.58%	+808,999,900.00%
BRSP BrightSpire Capital	0.00%	-4.06%	-7.56%	-14.36%	-3.00%
MDV Modiv Industrial	0.00%	-1.99%	-3.47%	+7.46%	+20.65%
NXRT NexPoint Residential Trust	0.00%	+0.32%	-9.03%	-9.43%	-15.07%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBOT BridgeBio Oncology Therapeutics	2.75	Moderate Buy	$24.80	200.61% Upside
BRSP BrightSpire Capital	2.33	Hold	$6.50	26.58% Upside
MDV Modiv Industrial	2.00	Hold	$18.50	8.25% Upside
NXRT NexPoint Residential Trust	2.00	Hold	$22.00	-15.29% Downside

Current Analyst Ratings Breakdown

Latest MDV, NXRT, BRSP, and BBOT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	NXRT NexPoint Residential Trust	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
7/30/2026	BRSP BrightSpire Capital	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$7.00 ➝ $6.50
7/29/2026	BRSP BrightSpire Capital	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$6.50
7/27/2026	NXRT NexPoint Residential Trust	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/20/2026	NXRT NexPoint Residential Trust	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$18.00
7/15/2026	MDV Modiv Industrial	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
7/8/2026	BBOT BridgeBio Oncology Therapeutics	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Overweight
7/8/2026	BBOT BridgeBio Oncology Therapeutics	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$27.00
6/30/2026	NXRT NexPoint Residential Trust	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$27.00 ➝ $26.00
6/23/2026	MDV Modiv Industrial	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
6/22/2026	BBOT BridgeBio Oncology Therapeutics	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$22.00

(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBOT BridgeBio Oncology Therapeutics	N/A	N/A	N/A	N/A	$5.14 per share	N/A
BRSP BrightSpire Capital	$194.89M	3.33	$0.94 per share	5.49	$7.16 per share	0.72
MDV Modiv Industrial	$46.39M	3.80	$1.42 per share	12.03	$19.66 per share	0.87
NXRT NexPoint Residential Trust	$251.28M	2.63	$2.75 per share	9.46	$11.65 per share	2.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBOT BridgeBio Oncology Therapeutics	-$134.04M	-$2.05	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BRSP BrightSpire Capital	-$31.15M	-$0.23	N/A	8.42	N/A	-20.43%	7.01%	1.80%	N/A
MDV Modiv Industrial	$1.07M	-$0.41	N/A	11.24	N/A	0.33%	0.07%	0.03%	8/6/2026 (Estimated)
NXRT NexPoint Residential Trust	-$32.03M	-$1.27	N/A	14.04	N/A	-12.67%	-10.30%	-1.71%	8/4/2026 (Estimated)

Latest MDV, NXRT, BRSP, and BBOT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	MDV Modiv Industrial	$0.03	N/A	N/A	N/A	$11.56 million	N/A
8/4/2026	Q2 2026	NXRT NexPoint Residential Trust	-$0.37	N/A	N/A	N/A	$63.78 million	N/A
7/28/2026	Q2 2026	BRSP BrightSpire Capital	$0.1488	$0.13	-$0.0188	-$0.15	$64.31 million	$48.70 million
5/12/2026	Q1 2026	BBOT BridgeBio Oncology Therapeutics	N/A	-$526.11	N/A	-$526.11	N/A	N/A
5/8/2026	Q1 2026	MDV Modiv Industrial	$0.0133	-$0.11	-$0.1233	-$0.11	$11.43 million	$11.70 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBOT BridgeBio Oncology Therapeutics	N/A	N/A	N/A	N/A	N/A
BRSP BrightSpire Capital	$0.64	12.46%	+16.36%	N/A	N/A
MDV Modiv Industrial	$1.20	7.02%	N/A	N/A	3 Years
NXRT NexPoint Residential Trust	$2.12	8.16%	+9.98%	N/A	3 Years

Latest MDV, NXRT, BRSP, and BBOT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/27/2026	NXRT NexPoint Residential Trust	quarterly	$0.53	7.85%	9/15/2026	9/15/2026	9/30/2026
6/10/2026	MDV Modiv Industrial	monthly	$0.10	7.02%	8/3/2026	8/3/2026	8/10/2026
6/15/2026	BRSP BrightSpire Capital	quarterly	$0.16	11.73%	6/30/2026	6/30/2026	7/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBOT BridgeBio Oncology Therapeutics	N/A	6.16	6.16
BRSP BrightSpire Capital	2.75	0.83	0.83
MDV Modiv Industrial	N/A	0.10	0.10
NXRT NexPoint Residential Trust	5.75	2.40	2.40

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBOT BridgeBio Oncology Therapeutics	54.89%
BRSP BrightSpire Capital	56.57%
MDV Modiv Industrial	8.21%
NXRT NexPoint Residential Trust	76.61%

Insider Ownership

Company	Insider Ownership
BBOT BridgeBio Oncology Therapeutics	24.40%
BRSP BrightSpire Capital	2.81%
MDV Modiv Industrial	2.80%
NXRT NexPoint Residential Trust	16.63%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBOT BridgeBio Oncology Therapeutics	N/A	80.11 million	60.56 million	N/A
BRSP BrightSpire Capital	50	126.52 million	122.97 million	Optionable
MDV Modiv Industrial	10	10.32 million	10.04 million	Not Optionable
NXRT NexPoint Residential Trust	3	25.49 million	21.25 million	Optionable

MDV, NXRT, BRSP, and BBOT Headlines

Recent News About These Companies

NexPoint Residential Trust Q2 2026 earnings preview

57 minutes ago | msn.com

Flax Pond Capital LLC Makes New $4.05 Million Investment in NexPoint Residential Trust, Inc. $NXRT

July 31 at 4:09 AM | marketbeat.com

NexPoint Residential Trust (NYSE:NXRT) Dividend Draws Focus

July 30, 2026 | kalkinemedia.comK

NexPoint Residential Trust, Inc. (NYSE:NXRT) to Issue $0.53 Quarterly Dividend

July 29, 2026 | marketbeat.com

NexPoint Residential Trust (NYSE:NXRT) Rating Increased to Strong-Buy at Zacks Research

July 29, 2026 | marketbeat.com

NexPoint Residential Trust declares $0.53 dividend

July 28, 2026 | msn.com

NexPoint Residential Trust, Inc. Announces Quarterly Dividend

July 28, 2026 | prnewswire.com

Best Income Stocks to Buy for July 28th

July 28, 2026 | zacks.com

NexPoint Residential Trust (NXRT) to Post Quarterly Earnings on Tuesday

July 28, 2026 | americanbankingnews.com

NexPoint Residential Trust (NXRT) Expected to Post Earnings on Tuesday

July 28, 2026 | marketbeat.com

NexPoint Residential Trust (NYSE:NXRT) Shares Cross Below 50 Day Moving Average - Here's Why

July 25, 2026 | marketbeat.com

NexPoint Residential Trust, Inc. (NYSE:NXRT) Given Consensus Rating of "Reduce" by Brokerages

July 16, 2026 | marketbeat.com

NexPoint Residential Trust, Inc. Announces Second Quarter 2026 Earnings Conference Call

July 9, 2026 | prnewswire.com

Strs Ohio Lowers Stake in NexPoint Residential Trust, Inc. $NXRT

July 7, 2026 | marketbeat.com

NexPoint Residential Trust: A Discounted Sunbelt REIT Facing Critical Interest Increases

June 9, 2026 | seekingalpha.com

Why The NexPoint Residential Trust (NXRT) Story Is Shifting On Valuation, Dividends And Debt Risks

June 8, 2026 | finance.yahoo.com

NexPoint Residential Trust, Inc. (NXRT) Presents at Nareit REITweek: 2026 Investor Conference - Slideshow

June 3, 2026 | seekingalpha.com

NexPoint Residential Trust, Inc. to Participate at Nareit's REITWeek: 2026 Investor Conference

May 28, 2026 | prnewswire.com

NexPoint Residential Trust: Cheap On Paper But Headwinds Exist

May 18, 2026 | seekingalpha.com

NexPoint Residential Trust Q1 earnings preview

April 29, 2026 | msn.com

NXRT Surprise Drives Housing REIT Optimism NYSE Composite Today

April 29, 2026 | kalkinemedia.comK

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDV, NXRT, BRSP, and BBOT Company Descriptions

BridgeBio Oncology Therapeutics NASDAQ:BBOT

$8.25 +0.16 (+1.98%)

Closing price 04:00 PM Eastern

Extended Trading

$8.20 -0.04 (-0.55%)

As of 07:34 PM Eastern

We are a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Throughout this prospectus, we will refer to this as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any potential business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business or industry, we intend to focus on healthcare or healthcare related industries, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value. Our sponsor is an affiliate of Cormorant, a leading life sciences focused investment firm with over $2 billion in assets under management as of December 31, 2022. Our Chairperson and Chief Executive Officer, Bihua Chen, founded Cormorant and is the managing member of Cormorant. Since its inception in 2013, Cormorant has focused on the healthcare industry and invests, throughout their growth cycle, in companies that discover and develop therapeutic drugs or medical technology. Cormorant is an active life-science investor with investments in over 100 privately held, life science-focused companies over this period. Of these investments, over 50 have completed initial public offerings. Notable successes include Prometheus Biosciences, Inc., Turning Point Therapeutics, Inc., and MyoKardia, Inc., each of which has been acquired for more than $4 billion. Other notable successes include BridgeBio Pharma Inc. and Apellis Pharmaceuticals Inc., each of which is a public company with a market capitalization greater than $1 billion. Our executive offices are located at 200 Clarendon Street, 52nd Floor, Boston, MA.

BrightSpire Capital NYSE:BRSP

$5.14 +0.13 (+2.50%)

Closing price 03:59 PM Eastern

Extended Trading

$5.24 +0.11 (+2.12%)

As of 07:37 PM Eastern

BrightSpire Capital, Inc. operates as a commercial real estate (CRE) credit real estate investment trust in the United States and Europe. The company operates through Senior and Mezzanine Loans and Preferred Equity; Net Leased and Other Real Estate; and Corporate and Other segments. It focuses on originating, acquiring, financing, and managing a diversified portfolio of CRE debt investments consisting of first mortgage loans, senior loans, debt securities, mezzanine loans, and preferred equity investments, as well as net leased properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Colony Credit Real Estate, Inc. and changed its name to BrightSpire Capital, Inc. in June 2021. BrightSpire Capital, Inc. was incorporated in 2017 and is headquartered in New York, New York.

Modiv Industrial NYSE:MDV

$17.09 -0.23 (-1.33%)

Closing price 03:59 PM Eastern

Extended Trading

$17.10 +0.02 (+0.09%)

As of 07:34 PM Eastern

Modiv Industrial, Inc. is an internally managed REIT that is focused on single-tenant net-lease industrial manufacturing real estate. The Company actively acquires critical industrial manufacturing properties with long-term leases to tenants that fuel the national economy and strengthen the nation's supply chains.

NexPoint Residential Trust NYSE:NXRT

$25.97 -0.14 (-0.54%)

Closing price 03:59 PM Eastern

Extended Trading

$25.96 -0.02 (-0.06%)

As of 07:34 PM Eastern

NexPoint Residential Trust is a publicly traded REIT, with its shares listed on the New York Stock Exchange under the symbol "NXRT," primarily focused on acquiring, owning and operating well-located middle-income multifamily properties with "value-add" potential in large cities and suburban submarkets of large cities, primarily in the Southeastern and Southwestern United States. NXRT is externally advised by NexPoint Real Estate Advisors, L.P., an affiliate of NexPoint Advisors, L.P., an SEC-registered investment advisor, which has extensive real estate experience.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MDV, NXRT, BRSP, and BBOT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MDV, NXRT, BRSP, and BBOT Earnings

Compare Dividends

Latest MDV, NXRT, BRSP, and BBOT Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MDV, NXRT, BRSP, and BBOT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDV, NXRT, BRSP, and BBOT Company Descriptions

BridgeBio Oncology Therapeutics NASDAQ:BBOT

BrightSpire Capital NYSE:BRSP

Modiv Industrial NYSE:MDV

NexPoint Residential Trust NYSE:NXRT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MDV, NXRT, BRSP, and BBOT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MDV, NXRT, BRSP, and BBOT Earnings

Compare Dividends

Latest MDV, NXRT, BRSP, and BBOT Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MDV, NXRT, BRSP, and BBOT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDV, NXRT, BRSP, and BBOT Company Descriptions

BridgeBio Oncology Therapeutics NASDAQ:BBOT

BrightSpire Capital NYSE:BRSP

Modiv Industrial NYSE:MDV

NexPoint Residential Trust NYSE:NXRT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools